About Jasper Therapeutics
Jasper Therapeutics is a company based in Redwood City (United States) founded in 1999 by Judith Shizuru and Susan Prohaska.. Jasper Therapeutics has raised $84.1 million across 3 funding rounds from investors including Roche, ARE and Citadel. Jasper Therapeutics operates in a competitive market with competitors including BridgeBio, Moderna, Forge Biologics, Spark Therapeutics and Mereo BioPharma, among others.
- Headquarter Redwood City, United States
- Founders Judith Shizuru, Susan Prohaska
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$84.1 M (USD)
in 3 rounds
-
Latest Funding Round
$14.1 M (USD), Series A
Jan 09, 2020
-
Investors
Roche
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Jasper Therapeutics
Jasper Therapeutics has successfully raised a total of $84.1M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $14.1 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $14.1M
-
First Round
First Round
(06 Dec 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Series A - Jasper Therapeutics | Valuation | Roche |
|
| Dec, 2019 | Amount | Series A - Jasper Therapeutics | Valuation |
investors |
|
| Dec, 2019 | Amount | Series A - Jasper Therapeutics | Valuation | Qiming , Abingworth |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Jasper Therapeutics
Jasper Therapeutics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Roche, ARE and Citadel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare companies are funded by Qiming, a venture capital firm.
|
Founded Year | Domain | Location | |
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Jasper Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Jasper Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jasper Therapeutics Comparisons
Competitors of Jasper Therapeutics
Jasper Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Moderna, Forge Biologics, Spark Therapeutics and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jasper Therapeutics
Frequently Asked Questions about Jasper Therapeutics
When was Jasper Therapeutics founded?
Jasper Therapeutics was founded in 1999 and raised its 1st funding round 20 years after it was founded.
Where is Jasper Therapeutics located?
Jasper Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Jasper Therapeutics?
Ronald Martell is the current CEO of Jasper Therapeutics.
Is Jasper Therapeutics a funded company?
Jasper Therapeutics is a funded company, having raised a total of $84.1M across 3 funding rounds to date. The company's 1st funding round was a Series A of $35M, raised on Dec 06, 2019.
What does Jasper Therapeutics do?
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells. It offers Briquilimab a targeted anti c-Kit monoclonal antibody to deplete mast cells and diseased stem cells for chronic urticaria and lower to intermediate risk myelodysplastic syndromes.
Who are the top competitors of Jasper Therapeutics?
Jasper Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Who are Jasper Therapeutics's investors?
Jasper Therapeutics has 5 investors. Key investors include Roche, ARE, Citadel, Abingworth, and Qiming.